TickerFacts.

Axim Biotechnologies, Inc. (AXIM): Capital Expenditures

Annual figures by period end, from SEC filings.

Not updated since 2023-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the year ended 2015-12-31 (for example after a spin-off or a discontinued operation), while the year before it was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$0
Year ended 2023-12-31
$97.3K2014-12-31: $02015-12-31: -$16.8K2016-12-31: $02020-12-31: $97.3K2021-12-31: $40.5K2022-12-31: $8.7K2023-12-31: $0$0
2014-12-31 Capital Expenditures (USD) 2023-12-31
Period endedCapital ExpendituresChange YoYSource filing
2023-12-31$0-100.0%2024-04-16, From 2023-01-01
2022-12-31$8.7K-78.5%2024-04-16, From 2022-01-01
2021-12-31$40.5K-58.4%2023-04-17, From 2021-01-01
2020-12-31$97.3Kn/a2022-04-19, From 2020-01-01
No annual figure between 2016-12-31 and 2020-12-31.
2016-12-31$0n/m2017-09-14, From 2016-01-01
2015-12-31-$16.8Kn/c2017-09-14, From 2015-01-01
2014-12-31$0n/a2016-04-18, From 2014-01-01